← Back to Search

VR+TAU for Grief (DIANE Trial)

N/A
Waitlist Available
Research Sponsored by Universite du Quebec en Outaouais
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights

Summary

This trial is looking at whether a VR intervention can help mothers who experienced a perinatal loss. The investigators hypothesize that the VR-based intervention group will show significantly reduced symptoms related to grief, postnatal depression and general psychopathology after treatment relative to a treatment-as-usual (TAU) group.

Eligible Conditions
  • Grief
  • Perinatal

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Trial Design

2Treatment groups
Active Control
Group I: VR+TAUActive Control2 Interventions
Participants will participate first to a VR-based intervention and then to the TAU condition. The TAU condition is a homogenous standard program proposed by the Centre d'études et de recherché en intervention familiale (CERIF) at Université du Québec en Outaouais (UQO) based on group counseling offered to women and men who experienced a perinatal loss.
Group II: TAU+VRActive Control2 Interventions
Participants will be invited first to participate to the TAU condition and then to the VR-based intervention.

Find a Location

Who is running the clinical trial?

Universite du Quebec en OutaouaisLead Sponsor
13 Previous Clinical Trials
18,141 Total Patients Enrolled
Fonds de la Recherche en Santé du QuébecOTHER_GOV
82 Previous Clinical Trials
46,593 Total Patients Enrolled
Canadian Research Chair in Family Psychosocial HealthUNKNOWN
~8 spots leftby Sep 2025